🔍 Key Findings
- Fewer R1 margins (tumor on ink) were achieved in mast cell tumors (MCTs) when using 6–10 mm lateral margins versus 0–5 mm (7% vs. 55%; _P_ = .049).
- For soft tissue sarcomas (STSs), no benefit was seen in margin completeness between 0–5 mm vs. 6–10 mm lateral margins (41% vs. 43% R1).
- Overall R1 rates were 26% for MCTs and 42% for STSs following PNE.
- R scheme (“tumor on ink” = R1) had better interobserver agreement (83%) compared to ≤1 mm margin criteria (68% agreement).
- Complication rate was moderate (26%), but no surgeries required revision.
- Local recurrence/metastasis occurred in 14% of dogs, with 60% of those having R1 margins.
- Adjunctive therapy was considered clinically indicated in 46% of 0–5 mm margin cases vs. 24% of 6–10 mm cases.
- Histologic grade and tumor size were not predictive of margin completeness.

